ArticleACS omega2026
Desktop Fabrication of Plasmonic Nanoantennas with 10 nm Precision Using Field-Emission Scanning Probe Lithography.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We demonstrate a precise, stable, and cost-effective method for fabricating plasmonic nanostructures using scanning probe lithography (SPL). This approach enables the accurate and reproducible fabrication of plasmonic nanoantennas with line widths down to 40 nm and gap size approximately 25 nm. Furthermore, geometric parameters such as length and width can be continuously tuned with a precision of 10 nm. This method eliminates the need for expensive vacuum electron beam lithography equipment and can be performed using a simple, desktop ambient atomic force microscope (AFM). Both the materials and the pattern transfer processes utilized are standard, providing a novel, convenient, and low-cost pathway for the fabrication of nanophotonic devices.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.